0001209191-23-007655.txt : 20230207 0001209191-23-007655.hdr.sgml : 20230207 20230207180013 ACCESSION NUMBER: 0001209191-23-007655 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230203 FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shameze Rampertab CENTRAL INDEX KEY: 0001721810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 23596406 MAIL ADDRESS: STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP. STREET 2: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASENSUS SURGICAL, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 TW ALEXANDER DRIVE STREET 2: SUITE 160 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 1 TW ALEXANDER DRIVE STREET 2: SUITE 160 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX, INC. DATE OF NAME CHANGE: 20190712 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-03 0 0000876378 ASENSUS SURGICAL, INC. ASXC 0001721810 Shameze Rampertab C/O ASENSUS SURGICAL, INC. 1 TW ALEXANDER DRIVE, SUITE 160 DURHAM NC 27703 0 1 0 0 EVP, Chief Financial Officer Common Stock 2023-02-04 4 M 0 248512 0.00 A 342170 D Common Stock 2023-02-04 4 F 0 103998 0.75 D 238172 D Stock Options 0.75 2023-02-03 4 A 0 175000 0.00 A 2030-02-03 Common Stock 175000 175000 D Restricted Stock Units 0.00 2023-02-03 4 A 0 175000 0.00 A Common Stock 175000 175000 D Restricted Stock Units 0.00 2023-02-03 4 A 0 350000 0.00 A Common Stock 350000 350000 D Restricted Stock Units 0.00 2023-02-04 4 M 0 84270 0.00 D Common Stock 84270 0 D Restricted Stock Units 0.00 2023-02-04 4 M 0 19704 0.00 D Common Stock 19704 19704 D Restricted Stock Units 0.00 2023-02-04 4 M 0 19704 0.00 D Common Stock 19704 19704 D Restricted Stock Units 0.00 2023-02-04 4 M 0 62417 0.00 D Common Stock 62417 124833 D Restricted Stock Units 0.00 2023-02-04 4 M 0 62417 0.00 D Common Stock 62417 124833 D This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Vests one-third annually on each of February 3, 2024, 2025 and 2026, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement"). Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2024, 2025 and 2026, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement. Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock. PRSU award with time-based vesting in three equal installments on each of February 4, 2024, 2025 and 2026, and performance-based vesting only if designated corporate goals are met. Lapse of forfeiture restrictions on discretionary bonus RSUs. Lapse of forfeiture on second one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Lapse of forfeiture restrictions on second one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Lapse of forfeiture restrictions on one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2024 and 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on each of February 4, 2024 and 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement. /s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab 2023-02-07